<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Mycetozoal bloom in a hydroponic culture of garden cress (Lepidium sativum L.)
2
Mycielski approach for wind speed prediction
3
Myc—Is this the oncogene from Hell?
4
MYCN gain and MYCN amplification in a stage 4S neuroblastoma
5
MYCN Gene Copy Number Status Detected by FISH Method and Its Correlation with Outcome and Clinicopathological Variables in Childhood Neuroblastoma
6
MYCN in neuronal tumours
7
MYCN oncoprotein targets and their therapeutic potential
8
Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes α-Tubulin Acetylation and Cell Differentiation
9
MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells
10
Myco-agro sorbents: novel heavy metal sequesters
11
Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis?
12
Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis?
13
Mycobacteria and sarcoidosis
14
Mycobacteria in the environment of pig farms in the Czech Republic between 2003 and 2007
15
Mycobacteria in water, feedstocks and food: analysis of publications
16
Mycobacteria, but not mercury, induces metallothionein (MT) protein in striped bass, Morone saxitilis, phagocytes, while both stimuli induce MT in channel catfish, Ictalurus punctatus, phagocytes
17
Mycobacteria: Genetics of Resistance and Implications for Treatment
18
Mycobacterial ABC Transport System: Structure of the Primary Phosphate Receptor
19
Mycobacterial Antibodies Against BCG and M.Tuberculosis H37RA Do Not Recognize Pathogenic M.Tuberculosis Cells but Do Recognize Their Cytoplasmic Constituents
20
Mycobacterial Antibodies Against BCG and M.Tuberculosis H37RA Do Not Recognize Pathogenic M.Tuberculosis Cells but Do Recognize Their Cytoplasmic Constituents
21
Mycobacterial disease in renal allograft recipients
22
Mycobacterial disease: A historical and epidemiologic perspective
23
Mycobacterial DNA Gyrase: Enzyme Purification and Characterization of Supercoiling Activity
24
Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis
25
Mycobacterial formulation in liposomes showed decreased expression of CD95/CD95L and caspase activity in T cells of leprosy patients
26
Mycobacterial Gene Cloning and Expression, Comparative Genomics, Bioinformatics and Proteomics in Relation to the Development of New Vaccines and Diagnostic Reagents
27
Mycobacterial granulomas: keys to a long-lasting host–pathogen relationship
28
Mycobacterial HSP70 as an adjuvant in the design of an idiotype vaccine against a murine lymphoma
29
Mycobacterial infection and the impact of rifabutin treatment in organ transplant recipients: a single-center study
30
Mycobacterial infections in multiple species: Implications for diagnosis and control
31
Mycobacterial Phenolic Glycolipid Virulence Factor Biosynthesis: Mechanism and Small-Molecule Inhibition of Polyketide Chain Initiation Original Research Article
32
Mycobacterial protein boosts BCG immunity
33
Mycobacteriosis in fishes: A review
34
MYCOBACTERIUM ULCERANS INFECTION (BURULI ULCER): FIRST REPORTED CASE IN A TRAVELER
35
Mycobacterium abscessus in a long-term respiratory care unit
36
Mycobacterium arupense among the isolates of non-tuberculous mycobacteria from human, animal and environmental samples
37
Mycobacterium Avium and Mycobacterium intracellulare Infections in Slaughtered Pigs in Makurdi, North-Central Nigeria: An Emerging Zoonosis
38
Mycobacterium avium Complex Extracellular Vesicles Attenuate Inflammation via Inducing IL-10
39
Mycobacterium avium subsp. avium in domestic pigeons (Columba livia f. domestica) diagnosed by direct conventional multiplex PCR: a case report
40
Mycobacterium avium subsp. Paratuberculosis in a mouflon herd without clinical symptoms monitored using IS900 real-time PCR: a case report
41
Mycobacterium avium subsp. paratuberculosis in muscle, lymphatic and organ tissues from cows with advanced Johneʹs disease
42
Mycobacterium avium subsp. paratuberculosis induces differential cytosine methylation at miR-21 transcription start site region
43
Mycobacterium avium subsp. paratuberculosis survival during fermentation of soured milk products detected by culture and quantitative real time PCR methods
44
Mycobacterium avium subspecies paratuberculosis bacteraemia in patients with inflammatory bowel disease
45
Mycobacterium Avium Subspecies Paratuberculosis Multibacillary Infection (Johne’s disease) ina Teddy Goat
46
Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages
47
Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages
48
Mycobacterium avium subspecies paratuberculosis: A possible causative agent in human morbidity and risk to public health safety
49
Mycobacterium avium subspecies paratuberculosis: the nature of the problem
50
Mycobacterium avium subspecies paratuberculosisA Review of Present Research in Norway
51
Mycobacterium aviumComplex Activates Nuclear Factor κB via Induction of Inflammatory Cytokines
52
Mycobacterium aviumReduces Expression of Costimulatory/Adhesion Molecules by Human Monocytes
53
Mycobacterium bovis AN5 antigens vary in their ability to induce nitric oxide production in blood monocytes of experimentally infected cattle
54
Mycobacterium bovis AN5 antigens vary in their ability to induce nitric oxide production in blood monocytes of experimentally infected cattle
55
Mycobacterium bovis Bacillus Calmette-Guérin (BCG) stimulates human β-defensin-2 gene transcription in human epithelial cells
56
Mycobacterium bovis Bacillus Calmette–Guérin (BCG) stimulates IL-10 production via the PI3K/Akt and p38 MAPK pathways in human lung epithelial cells
57
Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-induced activation of PI3K/Akt and NF-kB signaling pathways regulates expression of CXCL10 in epithelial cells
58
Mycobacterium bovis bacillus Calmette–Guérin (BCG)-induced CXCL8 production is mediated through PKCα-dependent activation of the IKKαβ signaling pathway in epithelial cells
59
Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection
60
Mycobacterium bovis BCG induces CXC chemokine ligand 8 secretion via the MEK-dependent signal pathway in human epithelial cells
61
Mycobacterium bovis BCG Toll-Like Receptors 2 and 4 Cooperation Increases the Innate Epithelial Immune Response
62
Mycobacterium bovis BCG vaccine induces non-specific immune responses in Japanese flounder against Nocardia seriolae
63
Mycobacterium bovis in Korea: An update
64
Mycobacterium bovis infection in badger cubs: Re-assessing the evidence for maternally derived immunological protection from advanced disease
65
Mycobacterium bovis infection in badger cubs: Re-assessing the evidence for maternally derived immunological protection from advanced disease
66
Mycobacterium bovis infection in domestic pigs in Great Britain
67
Mycobacterium bovis infection: Everything but the cow
68
Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 1: Review of epidemiology and laboratory submissions in Great Britain 2004–2010
69
Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 2: A review of diagnostic methods
70
Mycobacterium bovis tuberculins: Preparation and antigenic properties
71
Mycobacterium bovis tuberculosis: forgotten, but not gone
72
Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical administration of bacille Calmette-Guérin
73
Mycobacterium bovis: guidance on BCG vaccination is needed
74
Mycobacterium boviss Infection and Tuberculosis in Cattle
75
Mycobacterium chelonae interface infection after endokeratoplaty
76
Mycobacterium chelonae keratiti after laer in itu keratomileui uccefully treated with medical therapy and flap removal
77
Mycobacterium chelonae Keratitis Following Laser in situ Keratomileusis (LASIK) Specifically Identified by INNO-LIPA Method
78
Mycobacterium fortuitum prosthetic valve endocarditis: a case for the pathogenetic role of biofilms
79
Mycobacterium fortuitum-induced surgical wound infection - a case report
80
Mycobacterium gordonae in fiberoptic bronchoscopes
81
Mycobacterium leprae-induced demyelination: a model for early nerve degeneration
82
Mycobacterium marinum
83
Mycobacterium marinum as a cause of skin chronic granulomatous in the hand
84
Mycobacterium marinum hand infection: case reports and review of literature
85
Mycobacterium Marinum Infection after Infliximab Therapy
86
Mycobacterium marinum infection: A case report
87
Mycobacterium mucogenicum and Klebsiella pneumoniae Pulmonary Infection in a Patient Following Cardiac Surgery: A Case Report
88
Mycobacterium mucogenicum causing central line-related sepsis in a home parenteral nutrition patient
89
Mycobacterium mucogenicum meningitis due to external ventricular drain
90
Mycobacterium paratuberculosis and Milk
91
Mycobacterium paratuberculosis heat shock protein 70 as a tool in control of paratuberculosis
92
Mycobacterium paratuberculosis heat shock protein 70 as a tool in control of paratuberculosis
93
Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages
94
Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages
95
Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages
96
Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages
97
Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages
98
Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages
99
Mycobacterium simiae Isolates Subtypes and Molecular Drug Susceptibility in Iran
100
Mycobacterium Strain and Type of Resistance in Pulmonary Tuberculosis Patients: A Missed Link in Iran’s National Tuberculosis Plan
101
Mycobacterium Thermoresistibile Infection in a Child
102
Mycobacterium tuberculosis alters the differentiation of monocytes into macrophages in vitro
103
Mycobacterium tuberculosis and bovis as causes for shrinking bladder
104
Mycobacterium tuberculosis and Cryptococcus neoformans co-infection meningitis in a young immuncompetent woman
105
Mycobacterium tuberculosis and Dual M. tuberculosis/M. bovis Infection as the Cause of Tuberculosis in a Gorilla and a Lioness, Respectively, in Ibadan Zoo, Nigeria
106
Mycobacterium tuberculosis and lipids: Insights into molecular mechanisms from persistence to virulence
107
Mycobacterium tuberculosis and non-tubercular mycobacterium infection in women with unexplained infertility from eastern India
108
Mycobacterium tuberculosis and non-tubercular mycobacterium infection in women with unexplained infertility from eastern India
109
Mycobacterium tuberculosis and pemphigus vulgaris
110
Mycobacterium Tuberculosis Breast Infection Mimicking Pyogenic Abscesses in Kuwait
111
Mycobacterium tuberculosis Detection based on mpt64 amplification by Nested-PCR in Sputum samples
112
Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso
113
Mycobacterium tuberculosis genome sequence illuminates bugʹs biology
114
Mycobacterium tuberculosis GroEL Homologues Unusually Exist as Lower Oligomers and Retain the Ability to Suppress Aggregation of Substrate Proteins
115
Mycobacterium tuberculosis H37Rv3377c encodes the diterpene cyclase for producing the halimane skeleton
116
Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis
117
Mycobacterium tuberculosis Hsp16.3 Nonamers are Assembled and Re-assembled via Trimer and Hexamer Intermediates
118
Mycobacterium tuberculosis HspX/EsxS Fusion Protein: Gene Cloning, Protein Expression, and Purification in Escherichia coli
119
Mycobacterium tuberculosis infection and FHIT gene alterations in lung cancer
120
Mycobacterium tuberculosis infection in grazing cattle in central Ethiopia
121
Mycobacterium tuberculosis infection in travellers: tuberculosis comes home
122
Mycobacterium tuberculosis infection in women with unexplained infertility
123
Mycobacterium tuberculosis infection presenting with cutaneous abscess and osteomyelitis
124
Mycobacterium Tuberculosis Infection: Participation of TH1, TH2, TH17 and Regulatory T Cells in the Immune Response
125
Mycobacterium tuberculosis Inhibits MHC Class II Antigen Processing in Murine Bone Marrow Macrophages
126
Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation
127
Mycobacterium tuberculosis Protein Tyrosine Phosphatase PtpB Structure Reveals a Diverged Fold and a Buried Active Site
128
Mycobacterium tuberculosis Ribose-5-phosphate Isomerase has a Known Fold, but a Novel Active Site
129
Mycobacterium tuberculosis spoligotypes circulating in the Lebanese population: a retrospective study
130
Mycobacterium tuberculosis Thymidylate Kinase: Structural Studies of Intermediates along the Reaction Pathway
131
Mycobacterium tuberculosis transmission and HIV status
132
Mycobacterium tuberculosis transmission and HIV status
133
Mycobacterium tuberculosis transmission and HIV status
134
Mycobacterium tuberculosis β-ketoacyl-ACP reductase: α-Secondary kinetic isotope effects and kinetic and equilibrium mechanisms of substrate binding
135
Mycobacterium tuberculosis: a stowaway in the cell
136
Mycobacterium tuberculosisComplex DNA in Ancient Human Bones
137
Mycobacterium ulcerans
138
Mycobacterium ulcerans disease (Buruli ulcer) following human bite
139
Mycobacterium ulcerans infection Review Article
140
Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial
141
Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak
142
Mycobial enhancement of ergothioneine by submerged cultivation of edible mushroom mycelia and its application as an antioxidative compound
143
Mycobiota and aflatoxin B1 contamination of Piper guineense (Ashanti pepper), P. nigrum L. (black pepper) and Monodora myristica (calabash nutmeg) from Lagos, Nigeria
144
Mycobiota and aflatoxin B1 contamination of rainbow trout(Oncorhinchus mykiss) feed with emphasis toAspergillus section Flavi
145
Mycobiota and co-occurrence of mycotoxins in Capsicum powder
146
Mycobiota and identification of aflatoxin gene cluster in marketed spices in West Africa
147
Mycobiota and mycotoxin contamination of maize flours and popcorn kernels for human consumption commercialized in Spain Original Research Article
148
Mycobiota and mycotoxin producing fungi from cocoa beans
149
Mycobiota and mycotoxins in Brazil nut samples from different states of the Brazilian Amazon region
150
Mycobiota and mycotoxins in Brazilian peanut kernels from sowing to harvest
151
Mycobiota and mycotoxins present in finished fish feeds from farms in the Rio de Janeiro State, Brazil
152
Mycobiota and natural occurrence of aflatoxin, deoxynivalenol, nivalenol and zearalenone in rice freshly harvested in South Korea
153
Mycobiota and Toxigenecity Profile of Aspergillus flavus Recovered from Food and Poultry Feed Mixtures in Cameroon
154
Mycobiota associated with larval mines of Thrypticus truncatus and T. sagittatus (Diptera, Dolichopodidae) on waterhyacinth, Eichhornia crassipes, in Argentina
155
Mycobiota Associated with Sugarcane (Saccharum officinarum L.) Cultivars in Iraq.
156
Mycobiota Associated with Sugarcane (Saccharum officinarum L.) Cultivars in Iraq.
157
Mycobiota in the processing areas of two different meat products
158
Mycobiota of cocoa: From farm to chocolate Original Research Article
159
Mycobiota of the arid Middle East: check-list of novel fungal taxa introduced from 1940 to 2000 and major recent biodiversity titles
160
Mycocutaneous atypical mycobacterial infections in acquired immunodeficiency syndrome
161
Mycoediketopiperazine, a novel fungal metabolite from a Papularia sp.
162
Mycoflora and absence of aflatoxin contamination of commercialized cassava chips in Benin, West Africa
163
Mycoflora and mycotoxins in field samples of Brazil nuts
164
Mycoflora and natural occurrence of aflatoxins and fumonisin B1 in cassava and yam chips from Benin, West Africa
165
Mycoflora and nutritional components of cocoa powder samples in South West Nigeria
166
Mycoflora and occurrence of aflatoxin in dried vegetables in Benin, Mali and Togo, West Africa
167
Mycoflora and ochratoxin A producing strains of Aspergillus in Algerian wheat
168
Mycoflora and Water Quality index Assessment of Water Sources in Oproama, Niger Delta, Nigeria
169
Mycoflora associated with cucurbits
170
Mycoflora Associated with Some Textiles in Jeddah City
171
Mycoflora associated with stored seeds of soybean
172
Mycoflora associated with tomato during the process of marketing
173
Mycoflora of Fungal Contamination in Wheat Storage (Silos) in Golestan Province, North of Iran
174
Mycoflora of Fungal Contamination in Wheat Storage (Silos) in Golestan Province, North of Iran
175
Mycoflora of human external auditory canal in Shiraz, southern Iran
176
Mycoflora of Ostrich (Struthio camelus) gastrointestinal tract as a human hazard
177
Mycoflora of paddy and milled rice produced in the region of Northeastern Argentina and Southern Paraguay
178
Mycoflora of pistachio and peanut kernels from Sari, Iran
179
Mycoflora of pistachio and peanut kernels from Sari, Iran
180
Mycoflora of the Interdigital Spaces Among Girl Students in Ahvaz, Iran
181
Mycogenesis of cerium oxide nanoparticles using Aspergillus niger culture filtrate and their applications for antibacterial and larvicidal activities
182
Mycogenesis of silver nanoparticles by different Aspergillus species
183
Mycogenic nanoparticles and their bio‑prospective applications: current status and future challenges
184
Myco-heterotroph/epiparasitic plant interactions with ectomycorrhizal and arbuscular mycorrhizal fungi
185
Mycohydrometallurgy: Biotransformation of double refractory gold ores by the fungus, Phanerochaete chrysosporium
186
Myco-hydrometallurgy: Coal model for potential reduction of preg-robbing capacity of carbonaceous gold ores using the fungus, Phanerochaete chrysosporium
187
Mycoinsecticides and Mycoacaricides: A comprehensive list with worldwide coverage and international classification of formulation types
188
Mycolactones and Mycobacterium ulcerans disease
189
Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis Original Research Article
190
Mycolic Acids Constitute a Scaffold for Mycobacterial Lipid Antigens Stimulating CD1-Restricted T Cells Original Research Article
191
Mycological and histopathological findings of experimental disseminated candidiasis in dogs
192
Mycological aspects of onychomycosis in Khuzestan Province, Iran: A shift from dermatophytes towards yeasts
193
Mycological assessment of sediments in Ligurian beaches in the Northwestern Mediterranean: Pathogens and opportunistic pathogens
194
Mycological Evaluation of Imported Frozen Fish
195
Mycological evaluation of the phylloplane of Vigna unguiculata (L.) Walp
196
Mycological Identification of Some Fungi Isolated from Meat Products and Spices with Molecular Identification of Some Penicillium Isolates
197
Mycological investigation in patients with acute otitis media
198
Mycological Microscopic and Culture Examination of 400 Bronchoalveolar Lavage (BAL) Samples
199
Mycological quality and mycotoxin contamination of Sri Lankan peppers (Piper nigrum L.) and subsequent exposure assessment
200
Mycological Study of Superficial-cutaneous Mycoses in Tehran, Iran
201
Mycological Survey and Total Aflatoxin Analyze in Silage from Qaemshahr City (Northern Iran)
202
Mycological survey of ripped service tree fruits (Sorbus domestica L.) with an emphasis on toxinogenic fungi
203
Mycoparasitism of Ampelomyces quisqualis Ces. ex Schlecht on Powdery Mildew Fungi in Syria
204
Mycoparasitism of Pythium ultimum by Antagonistic Binucleate Rhizoctonia Isolates in Agar Media and on Capsicum Seeds
205
Mycoparasitism of Rhizoctonia solani by Endophytic Chaetomium spirale ND35: Ultrastructure and Cytochemistry of the Interaction
206
Mycophenolate mofetil
207
Mycophenolate mofetil - a new treatment for autoimmune hepatitis?
208
Mycophenolate Mofetil (MMF) Efficacy in Glomerulonephritis (GN), a Retrospective Analysis
209
Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
210
Mycophenolate Mofetil Ameliorates Perivascular T Lymphocyte Inflammation and Reduces the Double-Negative T Cell Population in SLE-Prone MRLlpr/lpr Mice
211
Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum
212
Mycophenolate mofetil associated with progressive multifocal leukoencephalopathy with successful outcome
213
Mycophenolate Mofetil Decreases Atherosclerotic Lesion Size by Depression of Aortic T-Lymphocyte and Interleukin-17–Mediated Macrophage Accumulation
214
Mycophenolate mofetil for Crohnʹs disease?
215
Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine
216
Mycophenolate Mofetil for Obliterative Bronchiolitis Syndrome After Lung Transplantation
217
Mycophenolate mofetil for prevention of acute rejection
218
Mycophenolate mofetil for severe autoimmune haemolytic anemia
219
Mycophenolate mofetil for systemic vasculitis and IgA nephropathy
220
Mycophenolate Mofetil for the Treatment of Uveiti Original Reearch Article
221
Mycophenolate mofetil for transplantation: new drug, old problems?
222
Mycophenolate Mofetil for Treatment of Idiopathic Nephrotic Syndrome in Children
223
Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome
224
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: a preliminary study
225
Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C
226
Mycophenolate mofetil in Crohnʹs disease
227
Mycophenolate mofetil in IBD patients
228
Mycophenolate Mofetil in Low Doses Stabilizes and Improves Antineutrophil Cytoplasmic Antibody-associated Vasculitis and Lupus Nephritis
229
Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite
230
Mycophenolate mofetil monotherapy in liver transplantation
231
Mycophenolate mofetil prevents the development of experimental autoimmune myocarditis
232
Mycophenolate mofetil to rescue children with acute renal transplant rejection
233
Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit
234
Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial
235
Mycophenolate mofetil versus cyclophosphamide for therapy of lupus nephritis: an evidence-based case report from systematic reviews and metaanalyses
236
Mycophenolate Mofetil versus Cyclosporine in Children with Frequent Relapse Nephrotic Syndrome
237
Mycophenolate mofetil: a new therapeutic option in dermatology
238
Mycophenolate mofetil: What is its place in the treatment of autoimmune rheumatic diseases?
239
Mycophenolate Mofetil; A Review of Indications and Use in a Large Tertiary Hospital
240
Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients
241
Mycophenolate Sodium versus Mycophenolate Mofetil: A Review of Their Comparative Features
242
Mycophenolic acid analogs with a modified metabolic profile Original Research Article
243
Mycophenolic acid as a latent agonist of PPARγ
244
Mycophenolic Acid Concentration on Vietnamese Renal Transplant Recipients
245
Mycophenolic Acid Influences T Helper 2 (Th2) Cytokine Induced Expression of Intercellular Cell Adhesion Molecule-1 (ICAM-1) on Human Endothelial Cells
246
Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages
247
Mycophenolic acid-induced replication arrest, differentiation markers and cell death of androgen-independent prostate cancer cells DU145
248
Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation
249
Mycoplasma bovis and otitis in dairy calves in the United Kingdom
250
Mycoplasma bovis Infection with Enzootic Pneumonia Symptoms in a Beef Cattle Farm
251
Mycoplasma bovis-associated disease: Here, there and everywhere
252
Mycoplasma capricolum subsp. capripneumoniae, the cause of contagious caprine pleuropneumonia, comprises two distinct biochemical groups
253
Mycoplasma fermentans in joints of patients with rheumatoid arthritis and other joint disorders
254
Mycoplasma genitalium and Mycoplasma hominis infection in south Korea during 2018-2020
255
Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: Association with amniotic fluid cytokine levels and pregnancy outcome
256
Mycoplasma hominis infections occurring in cardiovascular surgical patients
257
Mycoplasma hominis parasitism of Trichomonas vaginalis
258
Mycoplasma hominis parasitism of Trichomonas vaginalis
259
Mycoplasma hominis parasitism of Trichomonas vaginalis
260
Mycoplasma host specificity: Fact or fiction?
261
Mycoplasma hyopneumoniae-derived lipid-associated membrane proteins induce apoptosis in porcine alveolar macrophage via increasing nitric oxide production, oxidative stress, and caspase-3 activation
262
Mycoplasma hyopneumoniae-derived lipid-associated membrane proteins induce apoptosis in porcine alveolar macrophage via increasing nitric oxide production, oxidative stress, and caspase-3 activation
263
Mycoplasma hyorhinis induces epithelial-mesenchymal transition in gastric cancer cell MGC803 via TLR4-NF-κB signaling
264
Mycoplasma hyorhinis infection of pigs selectively bred for high and low immune response
265
Mycoplasma hyorhinis infection of pigs selectively bred for high and low immune response
266
Mycoplasma Infection in Pyospermic Infertile and Healthy Fertile Men
267
Mycoplasma Infection in the Lungs of Cattle: The First Identification of Mycoplasma dispar in Iran
268
Mycoplasma ovipneumoniae induces inflammatory response in sheep airway epithelial cells via a MyD88-dependent TLR signaling pathway
269
Mycoplasma ovipneumoniae induces inflammatory response in sheep airway epithelial cells via a MyD88-dependent TLR signaling pathway
270
Mycoplasma pneumonia and Chlamydia pneumonia infection in patients admitted to Beheshti Hospital in Kashan with community-acquired pneumonia
271
Mycoplasma pneumonia in Cerebrospinal Fluids of Febrile Children With Neurologic Manifestations: A Cross Sectional Study, Tehran, Iran
272
Mycoplasma pneumonia infection and asthma: A clinical study
273
Mycoplasma pneumoniae and Recurrent Respiratory Tract Infection Within One Year After Treatment in Infants: Risk Factors and Prevalence
274
Mycoplasma pneumoniae causing nervous system lesion and SIADH in the absence of pneumonia
275
Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report
276
Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis
277
Mycoplasma pneumoniae Infection Among Children: A Systematic Review and Meta-analysis of Published Literature
278
Mycoplasma Pneumoniae Infection with Neurologic Complications
279
Mycoplasma pneumoniae pneumonia following assisted ventilation
280
Mycoplasma pneumoniae preceding Lemierre’s syndrome due to Fusobacterium nucleatum complicated by acute Epstein–Barr virus (EBV) infectious mononucleosis in an immunocompetent host
281
Mycoplasma Synoviae and other Associated Bacteria Causing Arthritis in Chicken
282
Mycoplasma wenyonii: A Causative Agent of New Mastitis in Dairy Cows
283
Mycoplasma-like organisms in Hodgkinʹs disease
284
Mycoplasma-pneumoniae-Induced Thrombotic Thrombocytopenic Purpura
285
Mycoplasmas – Identifying hosts for a stealth pathogen
286
Mycoplasmas and oncogenesis
287
Mycoplasmas and Their Antibiotic Resistance: The Problems and Prospects in Controlling Infections
288
Mycoplasmoses of ruminants in France: recent data from the national surveillance network
289
Mycoplasmosis in Slaughtered She-Camels: Pathological Studies
290
Mycoprotein Production from Date Waste Using Fusarium venenatum in a Submerged Culture
291
Myco-remediation of Dairy Wastewater by Naturally Attenuated Aspergillus sp. Responsible for Sulfate Reduction
292
Mycoremediation of Dichlorvos Pesticide Contaminated Soil by Pleurotus pulmonarius (Fries) Quelet
293
Mycorrhiza between Kobresia bellardii (All.) Degel and Terfezia boudieri Chatin
294
Mycorrhiza formation is not needed for early growth induction and growth-related changes in polyamines in Scots pine seedlings in vitro
295
Mycorrhizae activity and diversity in conventional and organic apple orchards from Brazil
296
Mycorrhizae activity and diversity in conventional and organic apple orchards from Brazil
297
Mycorrhizae confer aluminum resistance to tulip-poplar seedlings
298
Mycorrhizae support oaks growing in a phylogenetically distant neighbourhood
299
Mycorrhizae support oaks growing in a phylogenetically distant neighbourhood
300
Mycorrhiza-induced resistance against the root–knot nematode Meloidogyne incognita involves priming of defense gene responses in tomato
301
Mycorrhiza-induced resistance against the root–knot nematode Meloidogyne incognita involves priming of defense gene responses in tomato
302
Mycorrhiza-induced resistance in banana acts on nematode host location and penetration
303
Mycorrhiza-induced resistance in banana acts on nematode host location and penetration
304
Mycorrhiza-induced resistance: more than the sum of its parts?
305
Mycorrhiza-induced resistance: more than the sum of its parts?
306
Mycorrhizal alleviation of acid soil stress in the sweet potato (Ipomoea batatas)
307
Mycorrhizal alleviation of acid soil stress in the sweet potato (Ipomoea batatas)
308
MYCORRHIZAL ASSOCIATION IN SOME WEEDS OF curcuma longa FIELDS OF DISTRICT KASUR, PAKISTAN
309
Mycorrhizal association of maritime pine, Pinus pinaster, with Rhizopogon roseolus has contrasting effects on the uptake from soil and root-to-shoot transfer of 137Cs, 85Sr and 95mTc
310
Mycorrhizal colonisation improves fruit yield and water use efficiency in watermelon (Citrullus lanatus Thunb.) grown under well-watered and waterstressed conditions
311
Mycorrhizal colonization and nitrogen uptake by maize: combined effect of tropical earthworms and velvetbean mulch
312
Mycorrhizal colonization of major banana genotypes in six East African environments
313
Mycorrhizal colonization with Glomus intraradices and development stage of transformed tomato roots significantly modify the chemotactic response of zoospores of the pathogen Phytophthora nicotianae
314
Mycorrhizal colonization with Glomus intraradices and development stage of transformed tomato roots significantly modify the chemotactic response of zoospores of the pathogen Phytophthora nicotianae
315
Mycorrhizal communities in relation to biomass production and nutrient use efficiency in two varieties of Douglas fir (Pseudotsuga menziesii var. menziesii and var. glauca) in different forest soils
316
Mycorrhizal communities in relation to biomass production and nutrient use efficiency in two varieties of Douglas fir (Pseudotsuga menziesii var. menziesii and var. glauca) in different forest soils
317
Mycorrhizal dependency of Chihuahuan Desert plants is influenced by life history strategy and root morphology
318
Mycorrhizal effects on nutrient cycling, nutrient leaching and N2O production in experimental grassland
319
Mycorrhizal effects on nutrient cycling, nutrient leaching and N2O production in experimental grassland
320
Mycorrhizal evolution
321
Mycorrhizal fungi biodiversity in Canadian soils
322
Mycorrhizal fungi enhance accumulation and tolerance of chromium in sunflower (Helianthus annuus)
323
Mycorrhizal fungi increase biocontrol potential of Pseudomonas fluorescens
324
Mycorrhizal fungi increase biocontrol potential of Pseudomonas fluorescens
325
MYCORRHIZAL FUNGUS (GLOMUS MOSSAE) INOCULATION EFFECTS ON PERFORMANCE AND ROOT BIOMASS DEVELOPMENT OF CACAO SEEDLINGS IN THE NURSERY
326
Mycorrhizal impact on osmotic adjustment in Ocimum basilicum during a lethal drying episode
327
Mycorrhizal networks: des liaisons dangereuses?
328
Mycorrhizal phosphorus enhancement of plants in undisturbed soil differs from phosphorus uptake stimulation by arbuscular mycorrhizae over non-mycorrhizal controls
329
Mycorrhizal protection of chili plants challenged by Phytophthora capsici
330
Mycorrhizal symbiosis and response of sorghum plants to combined drought and salinity stresses
331
Mycorrhizal symbiosis effects on growth of chalk false-brome (Brachypodium pinnatum) are dependent on the environmental light regime
332
Mycorrhizas and tropical soil fertility
333
MYCORRHIZATION AND USE OF SUPERABSORBENT POLYMERS IN TARGETED PRODUCTION OF HARDWOODS PLANTING MATERIAL
334
Mycorrhization of fossil and living plants
335
Mycorrhization of the notabilis and sitiens tomato mutants in relation to abscisic acid and ethylene contents
336
Mycosis fungoides and alopecia areata: A case report
337
Mycosis fungoides and Sézary syndrome
338
Mycosis fungoides during the COVID-19 pandemic: a teledermatology study
339
Mycosis Fungoides of the True Vocal Cord: A Case Report and Review of the Literature
340
Mycosis Fungoides Skin Wound Management With Skin Graft Post Ultraviolet Radiation therapy
341
Mycosis fungoides with an unusual clinicopathological presentation
342
Mycosphaerella graminicola produces a range of cell wall-degrading enzyme activities in vitro that vary with the carbon source
343
Mycosphaerella species associated with leaf disease of Eucalyptus globulus in Ethiopia
344
Mycosphaerella species occurring on Eucalyptus globulus and Eucalyptus nitens plantations of Tasmania, Australia
345
Mycosporine-like amino acid composition of the edible red alga, Palmaria palmata (dulse) harvested from the west and east coasts of Grand Manan Island, New Brunswick
346
Mycosporine-like amino acids (MAAs) protect against UV-B-induced damage in Gyrodinium dorsum Kofoid
347
Mycosporine-like amino acids in the marine dinoflagellate Gyrodinium dorsum: induction by ultraviolet irradiation
348
Mycosporine-like amino acids in the marine red alga Gracilaria cornea - effects of UV and heat
349
Mycosynthesis and characterization of selenium nanoparticles using standard penicillium chrysogenum PTCC 5031 and their antibacterial activity: A novel approach in microbial nanotechnology
350
Mycosynthesis of Silver Nanoparticles by Candida albicans Yeast and its Biological Applications
351
Mycosynthesis: Antibacterial, antioxidant and antiproliferative activities of silver nanoparticles synthesized from Inonotus obliquus (Chaga mushroom) extract
352
Mycotic Aneurysm of External Carotid Artery following Traumatic Brain Injury: Case Report and Review of Literature
353
Mycotic aneurysm of superior mesenteric artery branch presenting as pulsatile abdominal mass
354
Mycotic aneurysm of the aorta: Evolving surgical concept
355
Mycotic Aneurysm of the Descending Thoracic Aorta in a 2-kg Neonate
356
Mycotic Aneurysm of the Left Coronary Artery
357
Mycotic aneurysm of the left main coronary artery producing acute coronary occlusion and purulent pericarditis
358
Mycotic Aneurysm of the Thoracic Aorta Caused by Clostridium septicum
359
Mycotic aneurysm presenting as Pancoastʹs syndrome in an injection drug user
360
Mycotic aneurysm: A diagnostic challenge
361
Mycotic aneurysms of the abdominal aorta
362
Mycotic aneurysms of the thoracic aorta: a diagnostic challenge
363
Mycotic aortic aneurysm as a postsurgical complication: report of a case and review of the literature
364
Mycotic Aortic Aneurysm: Review of the Literature and Report of Two Cases
365
Mycotic Aortocoronary Saphenous Vein Graft Aneurysm Presenting With Unstable Angina Pectoris
366
Mycotic arch aneurysm and aortoesophageal fistula in a patient with melioidosis
367
Mycotic Coronary Artery Aneurysm From Fungal Prosthetic Valve Endocarditis
368
Mycotic false aneurysm of the ascending aorta
369
Mycotic infections in diabetic foot ulcers in Emam Reza hospital, Mashhad, 2006-2008
370
Mycotic infections in diabetic foot ulcers in Emam Reza hospital,Mashhad, 2006-2008
371
Mycotic Keratitis, a State-of-the-Art Review
372
Mycotic pseudoaneursym of the aortic arch: an unusual complication of invasive pulmonary aspergillosis
373
Mycotic pulmonary artery aneurysm diagnosed 18 years after bacterial endocarditis
374
Mycotoxicoses in veterinary medicine: Aspergillosis and penicilliosis
375
Mycotoxicosis in Swine: a Review
376
Mycotoxigenic and Proteolytic Potential of Moulds Associated with Smoked Shark Fish (Chlamydoselachus anguincus)
377
Mycotoxigenic Fusarium species in animal feed
378
Mycotoxin analyses in some home produced eggs in Belgium reveal small contribution to the total daily intake
379
Mycotoxin Contaminating Maize and Grass Silages for Dairy Cattle Feeding: Current State and Challenges
380
Mycotoxin Contamination of Foodstuffs and Feedstuffs in Iran
381
Mycotoxin Contamination of Maize Grains Grown in Karnataka (India)
382
Mycotoxin contamination of the feed supply chain: Implications for animal productivity and feed security
383
Mycotoxin content of organic and conventional oats from southeastern Poland
384
Mycotoxin fumonisin B1 selectively down-regulates the basal IL-8 expression in pig intestine: in vivo and in vitro studies
385
Mycotoxin Genetics and Gene Clusters
386
Mycotoxin glucosylation in commercial wheat varieties: Impact on resistance to Fusarium graminearum under laboratory and field conditions
387
Mycotoxin Management in Agriculture: a Review
388
Mycotoxin management in the European cereal trading sector
389
Mycotoxin occurrence in beer produced in several European countries
390
Mycotoxin occurrence in corn meal and flour traded in São Paulo, Brazil
391
Mycotoxin problem in Africa: Current status, implications to food safety and health and possible management strategies
392
Mycotoxin Production and Molecular Variability of European and American Isolates of Fusarium Culmorum
393
Mycotoxin production by Alternaria alternata strains isolated from red delicious apples in Argentina
394
Mycotoxin production by Alternaria strains isolated from Argentinean wheat
395
Mycotoxin production by Aspergillus, Fusarium and Penicillium species
396
Mycotoxin production by isolates of Fusarium lactis from greenhouse sweet pepper (Capsicum annuum)
397
Mycotoxin production in major crops as influenced by growing, harvesting, storage and processing, with emphasis on the achievement of Food Safety Objectives
398
Mycotoxin production of selected Fusarium species at different culture conditions
399
Mycotoxin protocols: Mary W. Trucksess and Albert E. Pohland (Eds.), Methods in Molecular Biology Inc., Volume 157, John M. Walker, Series Editor, Humana Press, Totowa, New Jersey 07512; 2000; hardback, pp xii+ 244; US$79.50; ISBN 0-089603-623-5; Website:
400
Mycotoxin Regulations for Foods: A Global Update
401
Mycotoxin research and mycoflora in some commercially important agricultural commodities
402
Mycotoxin risk evaluation in feeds contaminated by Aspergillus fumigatus
403
Mycotoxin-degradation profile of Rhodococcus strains
404
Mycotoxin-producing potential of fungi isolated from amaranth seeds in Argentina
405
Mycotoxins
406
Mycotoxins and food safety.: J.W. DeVries, M.W. Trucksess, L.S. Jackson (Eds.), 2002, Vol. 504, Advances in Experimental Medicine and Biology. Kluwer Academic, New York. 295+xi pp. ISBN 0-306-46780-1. Price?
407
Mycotoxins and food safety: Editors: Jonathan W. Devries, Mary W. Trucksess, and Lauren S. Jackson. Advances in Experimental Medicine and Biology, Vol. 504. Kluwer Academic, New York; xi+295 pp.; hardback, EUR 148.00/USD 135.00/GBP 94.00; ISBN 0-306-46780
408
Mycotoxins and phycotoxins. Advances in determination, toxicology and exposure management
409
Mycotoxins and Phycotoxins: Advances in Determination, Toxicology and Exposure Management, H. Njapeu, S. Trujillo, H. van Egmond, D. Pard (Eds.). Wageningen Academic Publishers (2006), ISBN: 978-90-8686-007-4
410
MYCOTOXINS AND SURFACE AND INTERNAL FUNGI OF MAIZE FROM ETHIOPIA
411
Mycotoxins and the pet food industry: Toxicological evidence and risk assessment
412
Mycotoxins and their effects on human and animal health
413
Mycotoxins Contamination in Tea and Herbal Infusion: A Mini-Review
414
Mycotoxins in a changing global environment – A review
415
Mycotoxins in Agriculture and Food Safety. K. K. Sinha and D. Bhatnagar (eds). 15.5 × 23.4 cm, 520 pp. New York, USA: Marcel Dekker [ http://www.dekker.com], 1998. $175. ISBN 0824701925 (hardback).
416
Mycotoxins in Brazilian corn for animal feed: occurrence and incentives for the private sector to control the level of contamination
417
Mycotoxins in cereals and cereal products in Slovenia – Official control of foods in the years 2008–2012
418
Mycotoxins in edible tree nuts
419
Mycotoxins in food from Jordan: Preliminary survey
420
Mycotoxins in food products available in Qatar
421
Mycotoxins in Food. Detection and Control, N. Magan, M. Olsen (Eds.). Woodhead Publishing Limited, Boca Raton, Boston, New York, Washington, DC, Cambridge (2004), ISBN: 1-85573-7337
422
Mycotoxins in fruits and their processed products: Analysis, occurrence and health implications
423
Mycotoxins in myelopathies of man
424
Mycotoxins in rice
425
Mycotoxins in Silages: Occurrence and Prevention
426
Mycotoxins in two Spanish cheese varieties
427
Mycotoxins occurrence in Argentina’s maize (Zea mays L.), from 1999 to 2010
428
Mycotoxins of Aspergilius fumigatus in pure culture and in native bioaerosols from compost facilities
429
Mycotoxins produced by Fusarium genus in maize: determination by screening and confirmatory methods based on liquid chromatography tandem mass spectrometry
430
Mycotoxins Produced by Fusarium spp. in Isogenic Bt vs. non-Bt Maize Hybrids under European Corn Borer Pressure
431
Mycotoxins: Occurrence, toxicology, and exposure assessment
432
Mycotoxins’ Toxicities - from Consumer Health Safety Concerns, to Mitigation/Treatment Strategies: A Perspective Review
433
Mycotrienins: A new class of potent inhibitors of osteoclastic bone resorption
434
MYCOTROPHIC STRATEGY OF 13 COMMON NEOTROPICAL TREES AND SHRUBS
435
Myctophid feeding ecology and carbon transport along the northern Mid-Atlantic Ridge
436
MyD88 pathway is involved in IL-18-mediated increase in intestine matrix metalloproteinase-9
437
Myectomy or Alcohol Septal Ablation: Surgery and Percutaneous Intervention Go Another Round
438
Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases
439
Myelin Basic Protein is Down-Regulated in Sheep Affected with Ovine Coenurosis
440
Myelin basic protein—diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis
441
Myelin basic protein–lipid complex: an atomic force microscopy study
442
Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases
443
Myelin breakdown in Alzheimer’s disease: a commentary
444
Myelin breakdown mediates age-related slowing in cognitive processing speed in healthy elderly men
445
Myelin characterization of fetal brain with mono-point estimated T1-maps
446
Myelin enhancement of Multiple sclerosis model with gold nanoparticles into the corpus callosum
447
Myelin Formation and Remodeling
448
Myelin Gene Regulatory Factor Is a Critical Transcriptional Regulator Required for CNS Myelination
449
Myelin glycoproteins targeted by lead in the rodent model of prolonged exposure
450
Myelin growth and coiling
451
Myelin Is a Preferential Target of Aluminum-Mediated Oxidative Damage
452
Myelin Membrane Wrapping of CNS Axons by PI(3,4,5)P3-Dependent Polarized Growth at the Inner Tongue
453
Myelin peptides in multiple sclerosis
454
Myelin Protection by Ursolic Acid in Cuprizone-Induced Demyelination in Mice
455
Myelin Proteolipid Protein-Induced Th1 and Th2 Clones Express TCR with Similar Fine Specificity for Peptide and CDR3 Homology Despite Diverse Vβ Usage
456
Myelin-Basic Protein-reactive Specific CD4+ and CD8+ NK Lymphocytes Induce Morphological Changes in Neuronal Cell Bodies and Myelin Sheaths: Implications for Multiple Sclerosis
457
Myelin-like protrusions of giant phospholipid vesicles prepared by electroformation
458
Myelin-Liposome Protection against Experimental Autoimmune Encephalomyelitis Is Associated with Reduced Neuroantigen-Specific T-Cell-Mediated Responses
459
Myelin-Oligodendrocyte Glycoprotein Antibodies Spectrum Disorders
460
Myelin-reactive antibodies mediate the pathology of MBP–PLP fusion protein MP4-induced EAE
461
Myelitis due to enterovirus in patient on interferon therapy for chronic hepatitis B: Case report
462
Myeloablative and immunosuppressive properties of treosulfan in mice
463
Myelodysplasia and Mast Cell Leukemia with t(9;22)
464
Myelodysplasia or Myeloneoplasia: Thoughts on the Nosology of Clonal Myeloid Diseases
465
Myelodysplasia with der(1;7)(q10;p10) discovered after an episode of bacterial lymphangitis in a twenty-three-year-old man
466
Myelodysplasia: The good, the fair and the ugly
467
Myelodysplasia: When to treat and how
468
Myelodysplasia-Like Syndrome and End-Stage Liver Disease
469
Myelodysplasic syndromes: A comprehensive review
470
Myelodysplastic features and cellular senescence in autoimmune disorders: a pilot study on patients with collagen tissue disorders and immune thrombocytopenic purpura
471
Myelodysplastic syndrome accompanied by basophilia and eosinophilia with t(5;12)(q31;p13)
472
Myelodysplastic Syndrome after Regression of Transient Abnormal Myelopoiesis in a Down Syndrome Infant: Different Clonal Origin?
473
Myelodysplastic syndrome and a nonrandom chromosomal abnormality t(1;19):: an indolent pathologic entity
474
Myelodysplastic syndrome and aortic valve replacement: additions
475
Myelodysplastic Syndrome Associated with Monosomy 7 in a Child with Bloom Syndrome
476
Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study
477
Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype
478
Myelodysplastic syndrome in an infant: induction of remission by cyclosporin
479
Myelodysplastic Syndrome Manifesting As Sweet’s Syndrome and Brochiolitis Obliterative Organizing Pneumonia
480
Myelodysplastic syndrome presenting with clonal rearrangement isolated to chromosomal region 1q
481
Myelodysplastic Syndrome with 6q Deletion as the Sole Chromosome Abnormality in an Iranian Patient: A Case Report with Review of Literature
482
Myelodysplastic Syndrome with Atypical Eosinophilia in Association with Ring Chromosome 7: A Case Report
483
Myelodysplastic syndrome with biclonal monosomy 7 and trisomy 8 after treatment with cladribine (2-chloro-2-deoxyadenosine) and involved field radiation therapy
484
Myelodysplastic Syndrome with Clonal Eosinophilia Accompanied by Eosinophilic Pulmonary Interstitial Infiltration
485
Myelodysplastic Syndrome with Hypereosinophilia and a Nonrandom Chromosomal Abnormality dic(1;7): Confirmation of Eosinophil Clonal Involvement by Fluorescence In Situ Hybridization
486
Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma
487
Myelodysplastic syndrome with monosomy 7 in a patient with XY gonadal dysgenesis (incomplete testicular feminization)
488
Myelodysplastic syndrome with transformation to AML-M7 in a 46,XX male patient
489
Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring
490
Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing
491
Myelodysplastic syndromes with isolated deletion of the long arm of the chromosome X as a sole cytogenetic change
492
Myelodysplastic Syndromes With Nephrotic Syndrome
493
Myelofibrosis due to Secondary Hyperparathyroidism in a Case of Celiac Disease
494
Myelofibrosis in a 24-Year Old Nigerian
495
Myelofibrosis with myeloid metaplasia: Disease overview and non-transplant treatment options
496
Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemias
497
Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemias
498
Myelographic Applications in Newborn Healthy and Paraplegic Calves
499
Myeloid Antigen-positive T Cell Acute Lymphocytic Leukemia with t(14;18) and Trisomy 10: Report of a Case and Literature Review
500
Myeloid Cell Leukemia-1 (MCL-1) siRNA Therapy Showed Cytotoxic Effect on T Cells Acute Lymphoblastic Leukemia
501
Myeloid Cell Leukemia-1 Gene Expression and Clinicopathological Features in Myelodysplastic Syndrome
502
Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgen-independent prostate cancer cells and a tumor xenograft animal model
503
Myeloid cell trafficking and tumor angiogenesis
504
Myeloid differentiation (MyD) primary response genes in hematopoiesis
505
Myeloid differentiation in long term culture of human peripheral blood
506
Myeloid Leukemia Development in c-Cbl RING Finger Mutant Mice Is Dependent on FLT3 Signaling
507
Myeloid lineage of high proliferative potential human smooth muscle outgrowth cells circulating in blood and vasculogenic smooth muscle-like cells in vivo
508
Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs
509
Myeloid Progenitor Cell Proliferation and Mobilization Effects of BB10010, a Genetically Engineered Variant of Human Macrophage Inflammatory Protein-1α, in a Phase I Clinical Trial in Patients with Relapsed/Refractory Breast Cancer
510
Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice
511
Myeloid Sarcoma after Allogenic Stem Cell Transplantation forAcute Myeloid Leukemia: Successful Consolidation TreatmentApproaches in Two Patients
512
Myeloid sarcoma of the orbit
513
Myeloid Sarcoma of the peritoneum at older ages: A case report and review of literature
514
Myeloid sarcoma of the urinary bladder with cutaneous tumour seeding after percutaneous suprapubic catheterization
515
Myeloid Sarcoma Presenting as Rectosigmoid Tumour: A Case Report
516
Myeloid Sarcoma Presenting with Lateral Cervical Mass and Eosinophilia; a Diagnostic and Therapeutic Dilemma: Case Report
517
Myeloid Sarcoma: Case Series with Unusual Locations
518
Myeloid/natural killer cell precursor acute leukemia with tetraploidy
519
Myeloid-derived suppressor cell role in tumor-related inflammation
520
Myeloid-derived suppressor cells are increased in frequency but not maximally suppressive in peripheral blood of Type 1 Diabetes Mellitus patients
521
Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice
522
Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice
523
Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit+CD33−CD38− fraction of umbilical cord CD34+ cells
524
Myelolipomas and other fatty tumours of the adrenals
525
Myeloma aetiology and epidemiology
526
Myeloma appearance after local external beam radiotherapy jet: Is it a new entity?
527
Myeloma Ascites-A Favorable Outcome With Cyclophosphamide Therapy
528
Myeloma bone disease
529
Myeloma cells (5TMM) and their interactions with the marrow microenvironment
530
Myelomatous Pleural Effusion Case report and review of the literature
531
Myelomeningocele: Characterization of a surgically induced sheep model and its central nervous system similarities and differences to the human disease
532
Myelopathy due to hereditary multiple exostoses: CT and MR studies
533
Myelopathy following high voltage electrical injury: a case report
534
Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis
535
Myeloperoxidase −463G > A polymorphism and risk of primary lung cancer in a Korean population
536
Myeloperoxidase activity in chicken heterophils and adherent cells
537
Myeloperoxidase activity in chicken heterophils and adherent cells
538
Myeloperoxidase activity, fibrinogen concentrations and white blood cell counts in healthy and sick foals
539
Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure
540
Myeloperoxidase and C-Reactive Protein Have Combined Utility for Long-Term Prediction of Cardiovascular Mortality After Coronary Angiography
541
Myeloperoxidase and Horseradish Peroxidase Catalyze Tyrosine Nitration in Proteins from Nitrite and Hydrogen Peroxide
542
Myeloperoxidase as a Biomarker in Acute Coronary Syndrome: Beware of the Pitfalls
543
Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion
544
Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: Genetic determinants for atherosclerosis?
545
Myeloperoxidase in Equine Semen: Concentration and Localization during Freezing Processing
546
Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia
547
Myeloperoxidase Levels in Patients with PCOS and/or Obesity Before and After Metformin Treatment
548
Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease
549
Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome
550
Myeloperoxidase Predicts Progression of Carotid Stenosis in States of Low High-Density Lipoprotein Cholesterol Original Research Article
551
Myeloperoxidase-antineutrophil cytoplasmic antibody-associated sensorineural hearing loss
552
Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients
553
Myeloperoxidase-catalyzed formation of PCDD/F from chlorophenols
554
Myeloperoxidase-Catalyzed Oxidation of Tyrosine
555
Myeloperoxidase-catalyzed redox-cycling of phenol promotes lipid peroxidation and thiol oxidation in HL-60 cells
556
Myeloperoxidase-catalyzed taurine chlorination: Initial versus equilibrium rate
557
Myeloperoxidase-Dependent Generation of a Tyrosine Peroxide by Neutrophils
558
Myeloperoxidase-Dependent Loss of Malondialdehyde: A Limitation for Detecting Neutrophil-Mediated Lipid Peroxidation
559
Myeloperoxidase-generated oxidants and atherosclerosis
560
Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines
561
Myeloperoxidase-mediated oxidation of high-density lipoproteins: Fingerprints of newly recognized potential proatherogenic lipoproteins
562
Myelopoiesis and erythropoiesis in canine visceral leishmaniasis
563
Myelopoiesis and erythropoiesis in canine visceral leishmaniasis
564
Myelopoiesis and erythropoiesis in canine visceral leishmaniasis
565
Myelopoiesis and erythropoiesis in canine visceral leishmaniasis
566
Myelopoiesis and erythropoiesis in canine visceral leishmaniasis
567
Myelopoiesis and erythropoiesis in canine visceral leishmaniasis
568
Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates
569
Myeloproliferative disorders
570
Myeloproliferative disorders and its associated mutations
571
Myeloproliferative Neoplasm with Prominent Eosinophilia
572
Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy
573
Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy
574
Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice
575
Myeloprolipherative Disorder Type Chronic Myeloid Leucemia - Eosinophilic Form
576
Myeloprotection following cytotoxic damage: The sooner the better
577
Myeloprotective effect of Triticum aestivum Linn. grass against antineoplastic agents induced bone marrow toxicity in mice
578
Myenteric Denervation of the Gut with Benzalkonium Chloride: A Review of Forty Years of an Experimental Model
579
Myenteric denervation reduces the incidence of gastric tumors in rats
580
Myenteric plexus injury and apoptosis in experimental colitis
581
Myers effect and tachyon condensation Original Research Article
582
Myerson values for games with fuzzy communication structure
583
Myf-5 Revisited: Loss of Early Myotome Formation Does Not Lead to a Rib Phenotype in Homozygous Myf-5 Mutant Mice
584
Myhill–Nerode type theory for fuzzy languages and automata
585
Myiasis
586
Myiasis among slaughtered animals in Kashan, Iran: descriptive a veterinary entomological problem in the tropics
587
Myiasis in an 89-year-old man with non-hodgkin lymphoma.
588
Myiasis in Animals and Humans in Northeastern Anatolia
589
Myiasis of Mandible Due to Lucilia sericata, in Diabetic Woman Patient: A Case Report
590
Myiasis With Carcinoma in Situ of the Glans Penis: An Unusual Combination
591
MyLake—A multi-year lake simulation model code suitable for uncertainty and sensitivity analysis simulations
592
MyLake—A multi-year lake simulation model code suitable for uncertainty and sensitivity analysis simulations
593
Mylar™ and Teflon-AF™ as cell culture substrates for studying endothelial cell adhesion
594
MyLearningMentor: A Mobile App to Support Learners Participating in MOOCs
595
MyLifeBits: holding on to the present to preserve the past
596
Mylonite development in the Hercynian basement of Sardinia (Italy)
597
Mylonitic deformation of gabbro in the lower crust: A case study from the Pankenushi gabbro in the Hidaka metamorphic belt of central Hokkaido, Japan
598
Mylonitization in the lower plate of the Buckskin-Rawhide detachment fault, west-central Arizona: Implications for the geometric evolution of metamorphic core complexes
599
MyMessage: case-based reasoning and multicriteria decision making techniques for intelligent context-aware message filtering
600
Myo- and hepatotoxic effects of cultivated mushrooms in mice
601
MYO/ENDOTHELIAL DIFFERENTIATION OF HUMAN UMBILICAL CORD BLOOD-DERIVED STEM CELLS IN ISCHEMIC LIMB TISSUES
602
Myoblast alignment and differentiation on cell culture substrates with microscale topography and model chemistries
603
Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries
604
Myoblast Transplantation for Cardiac Repair: From Automyoblast to Allomyoblast Transplantation
605
Myoblast transplantation for heart failure
606
Myoblast transplants challenged in muscular dystrophy
607
Myoblasts and fibroblasts in stress urinary incontinence
608
Myocardial 99m-Tc tetrofosmin reverse redistribution as a possible marker of tissue at risk
609
Myocardial abscess with contained rupture: successful repair
610
Myocardial adaptation and efficiency in response to intensive physical training in elite speedskaters
611
Myocardial adaptation to ischaemia – the preconditioning phenomenon
612
Myocardial adenine nucleotides, glycogen, and Na,K-ATPase in patients with idiopathic dilated cardiomyopathy requiring mechanical circulatory support
613
Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload
614
Myocardial and cerebral oxygen delivery are not adversely affected by cocaine administration to early-gestation fetal sheep, , ,
615
Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10
616
Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent
617
Myocardial and pulmonary effects of aqueous oxygen with acute hypoxia
618
Myocardial and Systemic Iron Depletion in Heart Failure: Implications for Anemia Accompanying Heart Failure
619
Myocardial and vascular dysfunction in systemic sclerosis: The potential role of noninvasive assessment in asymptomatic patients
620
Myocardial anti-ischemic effect of BRX-235: Role of nitric oxide and reactive oxygen species
621
Myocardial Apoptosis and Infarction after Ischemia/Reperfusion Are Attenuated by κ-Opioid Receptor Agonist
622
Myocardial apoptosis in heterotopic murine heart transplant model of chronic rejection/graft vasculopathy
623
Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study
624
Myocardial Atrophy and Chronic Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Assist Device–Induced Myocardial Recovery
625
Myocardial atrophy in acquired immunodeficiency syndrome—associated wasting
626
Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X
627
Myocardial beta-adrenoceptor densityone month after acute myocardial infarctionpredicts left ventricular volumes at six months
628
Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy
629
Myocardial blood flow after chronic cardiac decentralization in anesthetized dogs: effects of ACE-inhibition
630
Myocardial blood flow and coronary flow reserve late after anatomical correction of transposition of the great arteries
631
Myocardial blood flow and efficiency in concentric and eccentric left ventricular hypertrophy
632
Myocardial blood supply by left ventricle-to-coronary artery channel: An old idea revisited
633
Myocardial blood-flow response during mental stress in patients with coronary artery disease
634
Myocardial bridge over the left anterior descending coronary artery: A case report and review of the literature
635
Myocardial Bridge: Surgical Outcome and Mid-term Follow up
636
Myocardial Bridging
637
Myocardial bridging causing transmural ischemia Successful coronary artery bypass surgery
638
Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease
639
Myocardial bridging in adult and pediatric patients with hypertrophic cardiomyopathy is not associated with poor outcome
640
Myocardial bridging in adult patients with hypertrophic cardiomyopathy
641
Myocardial bridging of coronary arteries: A risk factor for myocardial fibrosis?
642
Myocardial bridging of obtuse marginal branch of the left circumflex artery associated with congenital corrected transposition of the great arteries
643
Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy
644
Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy: Reply
645
Myocardial bridging of the posterolateral branches of the right coronary artery
646
Myocardial bridging of the ramus intermedius coronary artery
647
Myocardial bridging of the right coronary artery and emotional stress: A fatal link?
648
Myocardial bridging on left anterior descending coronary artery evaluated by multidetector computed tomography
649
Myocardial Bridging: Contemporary Understanding of Pathophysiology With Implications for Diagnostic and Therapeutic Strategies
650
Myocardial buffering capacity in ischemia preconditioned rat heads
651
Myocardial Capillaries and Coronary Flow Reserve
652
Myocardial capillary density in normal and diabetic male rats: Effect of bezafibrate
653
Myocardial capillary supply is limited in hypertrophic cardiomyopathy: A morphological analysis
654
Myocardial cell damage in human hypertension
655
Myocardial Cell Death and Apoptosis in Hibernating Myocardium
656
Myocardial cell lineages in the mammalian embryo: The second heart field
657
Myocardial collagen and fibronectin levels in patients with pulmonary atresia and ventricular septal defect
658
Myocardial Connexin43 Expression in Left Ventricular Hypertrophy Resulting from Aortic Regurgitation
659
Myocardial contractile dispersion: A new marker for the severity of cirrhosis?
660
Myocardial contractile dysfunction contributes to the development of heart failure in rats with aortic stenosis
661
Myocardial Contractile Effects of image-Arginine in the Human Allograft
662
Myocardial Contractile Reserve Accurately Predicts Positive Response to Cardiac Resynchronization Therapy
663
Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy
664
Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy
665
Myocardial Contractile Responsiveness to Endothelin-1 in the Post-infarction Rat Model of Heart Failure: Effects of Chronic Quinapril
666
Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography
667
Myocardial contrast echo effect: The dilemm of coronary blood flow and volume
668
Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction
669
Myocardial Contrast Echocardiography Demonstrates That Collateral Flow Can Preserve Myocardial Function Beyond a Chronically Occluded Coronary Artery
670
Myocardial Contrast Echocardiography Evolving as a Clinically Feasible Technique for Accurate, Rapid, and Safe Assessment of Myocardial Perfusion: The Evidence So Far Review Article
671
Myocardial contrast echocardiography for the detection of coronary artery disease
672
Myocardial Contrast Echocardiography for the Detection of Coronary Artery Stenosis: A Prospective Multicenter Study in Comparison With Single-Photon Emission Computed Tomography Original Research Article
673
Myocardial contrast echocardiography in acute myocardial infarction
674
Myocardial Contrast Echocardiography in Acute Myocardial Infarction Using Aortic Root Injections of Microbubbles in Conjunction With Harmonic Imaging: Potential Application in the Cardiac Catheterization Laboratory
675
Myocardial contrast echocardiography in human beings: Correlation of resting perfusion defects to sestamibi single photon emission computed tomography
676
Myocardial Contrast Echocardiography Perfusion Imaging: Still Waiting After All These Years
677
Myocardial contrast echocardiography to assess spontaneous reperfusion during myocardial infarction
678
Myocardial Contrast Echocardiography Versus Dobutamine Echocardiography for Predicting Functional Recovery After Acute Myocardial Infarction Treated With Primary Coronary Angioplasty
679
Myocardial Contrast Echocardiography Versus Thrombolysis in Myocardial Infarction Score in Patients Presenting to the Emergency Department With Chest Pain and a Nondiagnostic Electrocardiogram Original Research Article
680
Myocardial contrast echocardiography with a new calibration method can estimate myocardial viabilityin patients with myocardial infarction Original Research Article
681
Myocardial contrast echocardiography with power Doppler imaging
682
Myocardial contrast echocardiography, single-photon emission computed tomography, and regional function analysis for coronary stenosis description during vasodilator stress
683
Myocardial Contrast Echocardiography: An Innovative Technique to Assess Myocardial Perfusion in Hypertensive Patients
684
Myocardial contrast echocardiography: relation of collateral perfusion to extent of injury and severity of contractile dysfunction in canine model of coronary thrombosis and reperfusion
685
Myocardial contrast echocardiography: Reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent
686
Myocardial contrast versus dobutamine echocardiography as predictors of late functional recovery in acute myocardial infarction treated with primary PTC
687
Myocardial creatine kinase expression after left ventricular assist device support
688
Myocardial cytochrome c oxidase activity in Swedish moose (Alces alces L.) affected by molybdenosis
689
Myocardial damage after continuous aerobic and anaerobic exercise in rats
690
Myocardial Damage After TAVR Assessed With CMR: A New Piece in a Puzzle?
691
Myocardial damage and left ventricular dysfunction in patients with and without persistent negative t waves after q-wave anterior myocardial infarction
692
Myocardial damage and repair
693
Myocardial damage does not occur in untreated hyperthyroidism unless associated with congestive heart failure, ,
694
Myocardial damage in multisystem inflammatory syndrome associated with COVID‑19 in children and adolescents
695
Myocardial damage of the entire ventricular region in a patient with acute myocardial infarction
696
Myocardial Deformation and Rotational Profiles in Mitral Valve Prolapse
697
Myocardial deformation and ventricular vortices: physically-based imaging in clinical practice
698
Myocardial Deformation Imaging Based on Ultrasonic Pixel Tracking to Identify Reversible Myocardial Dysfunction Original Research Article
699
Myocardial Deformation Imaging by Two-Dimensional Speckle-Tracking Echocardiography in Comparison to Late Gadolinium Enhancement Cardiac Magnetic Resonance for Analysis of Myocardial Fibrosis in Severe Aortic Stenosis
700
Myocardial Deformation Indices in Patients with Significant Aortic Regurgitation: A Strain Rate Imaging Study
701
Myocardial deformation recovery from cine MRI using a nearly incompressible biventricular model
702
Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Chagas’ Disease: A Marker of Disease Severity Original Research Article
703
Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Muscular Dystrophy Original Research Article
704
Myocardial diastolic dysfunction at experimental diabetes mellitus—the role of nitric oxide
705
Myocardial disarray: an architectural disorganization linked with adrenergic stress?
706
Myocardial Distribution of Antegrade Cold Crystalloid and Tepid Blood Cardioplegia
707
Myocardial Doppler velocity imaging—a quantitative technique for interpretation of dobutamine echocardiography
708
Myocardial dysfunction after resuscitation from cardiac arrest: An example of global myocardial stunning
709
Myocardial Dysfunction and Adrenergic Cardiac Innervation in Patients With Insulin-Dependent Diabetes Mellitus
710
Myocardial Dysfunction Caused by Perinatal Asphyxia in Full-term Infants
711
Myocardial Dysfunction in Thalassemia Major: Comparison between Echocardiography and MRI
712
Myocardial dysfunction with coronary microembolization: Signal transduction through a sequence of no, TNFα and sphingosine
713
Myocardial Dysfunction: A Primary Cause of Death Due To Severe Malaria in A Plasmodium falciparum-Infected Humanized Mouse Model.
714
Myocardial dysfunction: hibernation and remodelling
715
Myocardial dysfunction: hibernation and remodelling
716
Myocardial edema: Comparison of effects on filling volume and stiffness of the left ventricle in rats and pigs
717
Myocardial effects of experimental acute brain death: Evaluation by hemodynamic and biological studies
718
Myocardial Effects of PDE5 Inhibition: More Function With Less Mass
719
Myocardial electrical impedance responds to ischemia and reperfusion in humans
720
Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease
721
Myocardial enterovirus infection with left ventricular dysfunction: benign disease compared with idiopathic dilated cardiomyopathy
722
Myocardial epithelial inclusions in a Holstein calf
723
Myocardial Expression Levels of Micro-Ribonucleic Acids in Patients With Left Ventricular Assist Devices: Signature of Myocardial Recovery, Signature of Reverse Remodeling, or Signature With No Name?
724
Myocardial Expression of Endothelin-1 in Murine Trypanosoma cruzi Infection
725
Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy Original Research Article
726
Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat
727
Myocardial Extracellular Matrix Remodeling with the Development of Pacing Induced Congestive Heart Failure: Contributory Mechanisms
728
Myocardial Extracellular Remodeling Is Associated With Ventricular Diastolic Dysfunction in Children and Young Adults With Congenital Aortic Stenosis
729
Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy
730
Myocardial extramedullary hematopoiesis following myocardial infarction
731
Myocardial factor for timing of surgery in asymptomatic patients with mitral regurgitation
732
Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients
733
Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with
734
Myocardial Fibrosis Associated with Aldosterone or Angiotensin II Administration: Attenuation by Calcium Channel Blockade
735
Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels
736
Myocardial Fibrosis Identified by Cardiac Magnetic Resonance Late Gadolinium Enhancement Is Associated With Adverse Ventricular Mechanics and Ventricular Tachycardia Late After Fontan Operation
737
Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone
738
Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice
739
Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death
740
Myocardial Flow Reserve in Long-Term Survivors of Repair of Anomalous Left Coronary Artery From Pulmonary Artery
741
Myocardial flow reserve in patients with a systemic right ventricle after atrial switch repair
742
Myocardial function and geometry in hypertensive subjects with low levels of afterload
743
Myocardial Function in Egyptian Pediatric Patients With Acute Nephritic Syndrome
744
Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5
745
Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone
746
Myocardial Function in the Working Mouse Heart Overexpressing Cardiac A1Adenosine Receptors
747
Myocardial Function of Horses Under Sedation with Romifidine Using Two-Dimensional Speckle Tracking
748
Myocardial Function of Hyperthyroid Rats in Presence of Diazepam in Langendorff Setup
749
Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging
750
Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy: Responders Versus Nonresponders Original Research Article
751
Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease
752
Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery Original Research Article
753
Myocardial Glucose Transport and Utilization in Patients With Type 2 Diabetes Mellitus, Left Ventricular Dysfunction, and Coronary Artery Disease Original Research Article
754
Myocardial Glucose Transporter GLUT1: Translocation Induced by Insulin and Ischemia
755
Myocardial Glycogen Depletion Cannot Explain the Cardioprotective Effects of Ischemic Preconditioning in the Rat Heart
756
Myocardial high-energy phosphate metabolism in patients with stable chronic dilated cardiomyopathy under a dobutamine-induced prolonged mild workload,
757
Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines
758
Myocardial Hydatid Cyst : An Uncommon Complication of Echinococcal Infection
759
Myocardial hydrophilic polymer emboli following cardiac catheterization: a case report and literature review
760
Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats
761
Myocardial IL-6 regulation by neurohormones—an in vitro superfusion study
762
Myocardial imaging in patients with defibrillator patch electrodes
763
Myocardial imaging with a new transpulmonary lipid-fluorocarbon echo contrast agent: Experimental studies in pigs
764
Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion
765
Myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery
766
Myocardial infarction after an ice-hockey match: Coincidence of myocardial bridging and coronary spasm
767
Myocardial infarction after aspirin cessation in stable coronary artery disease patients
768
Myocardial Infarction after Endoscopic Removal of Foreign Body
769
Myocardial Infarction After Oral Sumatriptan Use in a Woman with Normal Coronary Arteries
770
Myocardial infarction after partial left ventriculectomy
771
Myocardial infarction after partial left ventriculectomy: Reply
772
Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging Original Research Article
773
Myocardial infarction after vascular surgery: the role of prolonged, stress-induced, ST depression-type ischemia
774
Myocardial infarction and coronary care units
775
Myocardial infarction and depression: A review article
776
Myocardial infarction and heart failure—a dangerous intersection
777
Myocardial infarction and HELLP: a case of heightened vasomotor reactivity
778
Myocardial Infarction and Hyperglycemia
779
Myocardial infarction and ischemia
780
Myocardial infarction and left ventricular remodeling: Results of the CEDIM trial
781
Myocardial infarction and percent arteriographic stenosis of culprit lesion: Report from the Program on the Surgical Control of the Hyperlipidemias (POSCH) Original Research Article
782
Myocardial Infarction and Regulatory Myosin Light Chain
783
Myocardial infarction and sub-acute ventricular rupture: successful outcome in two cases
784
Myocardial infarction and venous thrombosis in a 42-year old woman with heterozygous methylenetetrahydrofolate reductase (MTHRF) gene mutation, hyperhomocysteinemia, and protein C deficiency
785
Myocardial infarction as a complication of new interventional devices
786
Myocardial infarction as complication of left atrial myxoma
787
Myocardial infarction caused by a large coronary artery aneurysm
788
Myocardial infarction caused by a leukemic clot: A case report
789
Myocardial Infarction Caused by Active-Fixation Ventricular Pacing Lead Screwed into the Anterior Descending Coronary Artery
790
Myocardial infarction caused by compression of the left coronary artery by an aortic pseudoaneurysm
791
Myocardial infarction caused by coronary artery myocardial bridge,
792
Myocardial infarction complicating the initial phase of an ovarian stimulation protocol
793
Myocardial infarction diagnosis by morphology of ventricular extrasystole
794
Myocardial infarction due to lightning strike
795
Myocardial infarction during menses: lessons from trials and errors
796
Myocardial infarction during scuba diving: A case report and review
797
Myocardial Infarction Elevates Inflammation and Contributes to the Formation of Atheroma Plaques in the Aorta of Hypercholesterolaemic Rats
798
Myocardial infarction following a bee sting
799
Myocardial infarction in a 35-day-old infant with incomplete Kawasaki disease and chicken pox
800
Myocardial Infarction in a newborn from a diabetic mother
801
Myocardial Infarction in a Patient with Prosthetic Aortic Valve
802
Myocardial infarction in a patient with thrombotic thrombocytopenic purpura
803
Myocardial infarction in a woman with no apparent risk factors
804
Myocardial infarction in a young athlete with non-obstructive hypertrophic cardiomyopathy and normal coronary arteries
805
Myocardial Infarction in a Young Patient After Acute Exposure to Carbon Monoxide
806
Myocardial infarction in a young woman with antiphospholipid syndrome
807
Myocardial infarction in children
808
Myocardial Infarction in Iran: Epidemiology, Management, and Prognosis
809
Myocardial infarction in isolated ventricular non-compaction: Contrast echo and MRI
810
Myocardial infarction in mice: Functional characterization and cytokine expression
811
Myocardial Infarction in Newly Diagnosed Hypertensive Medicaid Patients Free of Coronary Heart Disease and Treated with Calcium Channel Blockers
812
Myocardial Infarction in Patients with and without COVID-19: Comparisons of Characteristics, Clinical Courses, and Outcomes
813
Myocardial infarction in pregnant women — Case reports
814
Myocardial infarction in pre-war Leeds
815
Myocardial infarction in pre-war Leeds
816
Myocardial infarction in pre-war Leeds
817
Myocardial infarction in sickle-cell disease
818
Myocardial Infarction in the Absence of Obstructive Epicardial Coronary Disease
819
Myocardial infarction in the C57BL/6J mouse: A quantifiable and highly reproducible experimental model
820
Myocardial infarction in young adults: Angiographic characterization, risk factors and prognosis (coronary artery surgery study registry)
821
Myocardial infarction in young adults: Angiographic characterization, risk factors, and prognosis (Coronary Artery Surgery Study registry): Zimmerman FH, Cameron A, Fisher LD, et al J Am Coll Cardiol 26:654–661 September 1995
822
Myocardial infarction in young patients
823
Myocardial Infarction Induced by Migraine Therapy
824
Myocardial infarction occurrence in Jerusalem: a Mediterranean anomaly
825
Myocardial infarction or inflammation?
826
Myocardial infarction patients in the 1990s—their risk factors, stratification and survival in Canada: The Canadian assessment of myocardial infarction (CAMI) study
827
Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement
828
Myocardial infarction quantification with late gadolinium-enhanced magnetic resonance imaging in rats using a 7-T scanner
829
Myocardial infarction redefined: Impact on case-load and outcome of patients with suspected acute coronary syndrome and nondiagnostic ECG at presentation
830
Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/ American College of Cardiolo
831
Myocardial Infarction Resulting From Caffeine Overdose in an Anorectic Woman, ,
832
Myocardial infarction resulting from nonatherosclerotic coronary artery diseases
833
Myocardial infarction risk in relation to zinc concentration in toenails
834
Myocardial infarction scar plication in the rat: cardiac mechanics in an animal model for surgical procedures
835
Myocardial Infarction Secondary to a Coronary Ostial Thrombus in Antiphospholipid Syndrome
836
Myocardial Infarction Secondary to Inflammatory Myofibroblastic Tumor Obstruction of the Left Main: Treated With Primary PCI
837
Myocardial infarction with huge mural thrombus due to spontaneous coronary artery dissection detected by 64-multidetector computed tomography
838
Myocardial infarction with spontaneous reperfusion in a young woman with hypertrophic cardiomyopathy
839
Myocardial infarction with thrombus formation during prolonged intense exercise
840
Myocardial infarction without coronary artery occlusion following mental stress
841
Myocardial infarction, Arg 506 to Gin factor V mutation, and activated protein C resistance
842
Myocardial infarction, ventricular remodeling, and angiotensin-converting enzyme inhibition: Where we stand today
843
Myocardial Infarction, Viral Infection, and the Cytoskeleton: Final Common Pathways of a Common Disease?
844
Myocardial infarction: a catabolic disease?
845
Myocardial infarction: a paradigm of success in modern medicine
846
Myocardial infarction: a rare complication of dothiepin overdose
847
Myocardial infarction: changing view of a killer
848
Myocardial infarction: From trials to practice : Ball SG (editor) Wrightson Biomedical Publishing Ltd., Hampshire, UK, 1995; 194 pp.; stg£32.50; ISBN 1-871816-26-2
849
Myocardial infarction: is evidence-based medicine the best?
850
Myocardial Infarction-triggered Thrombotic Microangiopathy
851
Myocardial inflammatory infiltrate in human chronic chagasic cardiomyopathy: Immunohistochemical findings
852
Myocardial Injury After Electrical Therapy for Cardiac Arrhythmias Assessed by Troponin-T Release
853
Myocardial injury during off-pump surgery. The effect of intraoperative risk factors
854
Myocardial injury in thrombotic thrombocytopenic purpura: A frequent, perplexing complication
855
Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation
856
Myocardial injury-related changes in plasma NT-proBNP and ANP concentrations in a canine model of ischemic myocardial injury
857
Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: Prediction of response to β-blocker therapy
858
Myocardial integrated ultrasonic backscatter in patients with old myocardial infarction: Comparison with radionuclide evaluation
859
Myocardial involvement in a patient with human ehrlichiosis
860
Myocardial involvement in Takayasu arteritis
861
Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure: Results of the Prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) Study
862
Myocardial iron load measured by cardiac magnetic resonance imaging to evaluate cardiac systolic function in thalassemia
863
Myocardial ischaemia
864
Myocardial ischaemia un-masked by transesophageal atrial pacing combined with two-dimensional transthoracic echocardiography in a pediatric patient: a case report
865
Myocardial ischaemia with a normal coronary angiogram due to the primary antiphospholipid syndrome
866
Myocardial Ischemia Activates the JAK–STAT Pathway Through Angiotensin II Signaling in in vivo Myocardium of Rats
867
Myocardial ischemia and autonomic activity in dippers and non-dippers with coronary artery disease: assessment of normotensive and hypertensive patients
868
Myocardial ischemia and infarction Review Article
869
Myocardial Ischemia and Infarction Review Article
870
Myocardial Ischemia and Infarction Review Article
871
Myocardial ischemia and reperfusion injury
872
Myocardial ischemia and ventricular fibrillation: Pathophysiology and clinical implications
873
Myocardial Ischemia and Ventricular Tachycardia on Continuous Electrocardiographic Monitoring and Risk of Cardiovascular Outcomes After Non–ST-Segment Elevation Acute Coronary Syndrome (from the MERLIN-TIMI 36 Trial)
874
Myocardial ischemia caused by a coronary anomaly left anterior descending coronary artery arising from right sinus of Valsalva
875
Myocardial Ischemia Caused by an Abnormal Origin and Course of the Left Coronary Artery in an Adult
876
Myocardial ischemia caused by cold-water submersion
877
Myocardial ischemia caused by external compression due to shotgun bullets
878
Myocardial ischemia due to coronary artery spasm during dobutamine stress echocardiography
879
Myocardial ischemia during physical exercise in patients with stable coronary artery disease: predictability and prevention
880
Myocardial ischemia during sexual activity in patients with coronary artery disease
881
Myocardial ischemia in generalized coronary artery–left ventricular microfistulae
882
Myocardial Ischemia Induced by Rapid Atrial Pacing Causes Troponin T Release Detectable by a Highly Sensitive Assay: Insights From a Coronary Sinus Sampling Study
883
Myocardial ischemia induced by topical use of 5-fluorouracil
884
Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process
885
Myocardial Ischemic Injury and Purine Metabolism in Patients Undergoing Coronary Artery Bypass
886
Myocardial ischemic injury during cardiopulmonary by-pass: Evaluation of purine compounds by capillary electrophoresis
887
Myocardial ischemic post-conditioning protects the lung against myocardial ischemia/reperfusion-induced damage by activating GSK-3β
888
Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome
889
Myocardial kinematics from tagged MRI based on a 4-D B-spline model
890
Myocardial Kinetics of 99mTechnetium-Q Agents Studies in Isolated Cardiac Myocyte, Isolated Perfused Rat Heart, and Canine Regional Myocardial Ischemia Models
891
Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion
892
Myocardial lactate dehydrogenase subunit ratio in cardiac allograft recipients
893
Myocardial laser revascularization for the treatment of end-stage coronary artery disease
894
Myocardial laser revascularization: the controversy and the data
895
Myocardial Late Enhancement in Duchenne and Becker Individuals in the Clinical Milieu
896
Myocardial Metabolic Abnormality in a Primary Left Atrial Rhabdomyosarcoma: Localized 1H MR Spectroscopy
897
Myocardial metabolism and hemodynamics during coronary surgery without cardiopulmonary bypass
898
Myocardial Metabolism is Better Preserved After Blood Cardioplegia in Infants
899
Myocardial microvascular abnormalities observed by intravenous myocardial contrast echocardiography in patients with hypertrophic cardiomyopathy
900
Myocardial mitochondrial calcium accumulation modulates nuclear calcium accumulation and DNA fragmentation
901
Myocardial Motion Analysis From B-Mode Echocardiograms
902
Myocardial myotonia in myotonic muscular dystrophy
903
Myocardial necrosis in “pure unstable angina”: Identification of high-risk subgroups or a contradiction in terms?, ,
904
Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis
905
Myocardial No-Reflow in Humans
906
Myocardial outflow of prostacyclin in relation to metabolic stress during off-pump coronary artery bypass grafting
907
Myocardial Oxygen Consumption Modulates Adenosine Formation by Canine Right Ventricle in Absence of Hypoxia
908
Myocardial oxygen consumption: The quest for its determinants and some clinical fallout
909
Myocardial oxygen consumption: the quest for its determinants and some clinical fallout
910
Myocardial Oxygen Tension and Relative Capillary Density in Isolated Perfused Rat Hearts
911
Myocardial Oxygen Tension in Isolated Erythrocyte-perfused Rat Hearts and Comparison with Crystalloid Medi
912
Myocardial Oxygenation During Terminal Warm Blood Cardioplegia
913
Myocardial Oxygenation in Coronary Artery Disease: Insights From Blood Oxygen Level–Dependent Magnetic Resonance Imaging at 3 Tesla
914
Myocardial parasite persistence in chronic chagasic patients
915
Myocardial pathological changes in overtraining exercise
916
Myocardial perforation associated with the use of the Gensini ventriculography catheter
917
Myocardial performance after graft preservation and subsequent cardiac transplantation from brain-dead donors
918
Myocardial performance after successful intervention for native aortic coarctation
919
Myocardial Performance after Successful Liver Transplantation
920
Myocardial perfusion abnormalities during low-dose dobutamine after coronary reperfusion can be demonstrated with intravenous perfluorocarbon-exposed sonicated dextrose albumin ultrasound contrast
921
Myocardial perfusion abnormality and necrosis in a patient with isolated noncompaction of the ventricular myocardium: Evaluation by myocardial perfusion SPECT and magnetic resonance imaging
922
Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction
923
Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-up
924
Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy
925
Myocardial Perfusion and Ventricular Function Assessed by SPECT and Gated-SPECT in End-Stage Renal Disease Patients before and after Renal Transplant
926
Myocardial perfusion and viability by positron emission tomography in infants and children with coronary abnormalities: correlation with echocardiography,coronary angiography, and histopathology
927
Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography
928
Myocardial perfusion before and after single routine LDL-apheresis
929
Myocardial perfusion during warm antegrade and retrograde cardioplegia: a contrast echo study
930
Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock
931
Myocardial Perfusion Imaging and Multidetector Computed Tomographic Coronary Angiography: Appropriate for All Patients With Suspected Coronary Artery Disease?
932
Myocardial Perfusion Imaging During Adenosine-Induced Coronary Hyperemia
933
Myocardial perfusion imaging findings and the role of adenosine in the warm-up angina phenomenon
934
Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention Review Article
935
Myocardial Perfusion Imaging Study of CO2-Induced Panic Attack
936
Myocardial perfusion imaging with technetium-99m sestamibi in patients with cocaine-associated chest Pain
937
Myocardial perfusion in apical ballooning syndrome: Correlate of myocardial injury
938
Myocardial perfusion in children with sickle cell disease
939
Myocardial perfusion in patients with permanent ventricular pacing and normal coronary arteries
940
Myocardial perfusion in real-time using power modulation: In vivo evidence for microcirculatory damage after acute myocardial infarction
941
Myocardial perfusion magnetic resonance imaging for detecting coronary function anomalies in asymptomatic paediatric patients with a previous arterial switch operation for the transposition of great arteries
942
Myocardial Perfusion Magnetic Resonance Imaging Using Sliding-Window Conjugate-Gradient Highly Constrained Back-Projection Reconstruction for Detection of Coronary Artery Disease
943
Myocardial perfusion pattern in patients with cocaine-induced chest pain
944
Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy
945
myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging
946
Myocardial Perfusion Scintigraphy (Gated-SPECT) and Coronary Disease Risk Factors in Behçet’s Disease with Metabolic Syndrome
947
Myocardial Perfusion Scintigraphy and Value in Patients With Non-ST Segment Elevation Acute Coronary Syndromes
948
Myocardial perfusion single photon computed tomography: An Atlas
949
Myocardial perfusion SPECT and dobutamine stress tissue Doppler imaging in evaluation of patients with stable angina pectoris
950
Myocardial Perfusion SPECT Imaging in Dextrocardia with Situs Inversus: A Case Report
951
Myocardial perfusion SPECT: Perfusion quantification
952
Myocardial Perfusion Study of Panic Attacks in Patients With Coronary Artery Disease
953
Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers Original Research Article
954
Myocardial Preconditioning Produced by Ischemia, Hypoxia, and a KATPChannel Opener: Effects on Interstitial Adenosine in Dogs
955
Myocardial preservation during coronary surgery with and without cardiopulmonary bypass
956
Myocardial preservation using celsior solution in cardiac transplantation: early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations
957
Myocardial protection
958
Myocardial protection and esmolol in blood perfused rat hearts
959
Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor
960
Myocardial protection during antegrade versus retrograde cardioplegia
961
Myocardial Protection During Elective Coronary Artery Bypass Grafting Using High-Dose Insulin Therapy
962
Myocardial protection during reperfusion by administration of caspase-3 inhibitor is mediated via PI3 kinase survival pathway
963
Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases
964
Myocardial protection for acquired heart disease surgery: Results of a national survey
965
Myocardial protection for coronary bypass grafting: The Toronto Hospital perspective
966
Myocardial protection for neonatal cardiac surgery-the developmental status and ischemic damage in human heart cell
967
Myocardial protection in the immature heart
968
Myocardial Protection of Contractile Function After Global Ischemia by Physiologic Estrogen Replacement in the Ovariectomized Rat
969
Myocardial protection of the failing heart
970
Myocardial protection using diadenosine tetraphosphate with pharmacological preconditioning
971
Myocardial protection with endogenous overexpression of manganese superoxide dismutase
972
Myocardial protection with intermittent cold blood during aortic valve operation: antegrade versus retrograde delivery
973
Myocardial protection with intermittent cross-clamp fibrillation: Improvement with sodium-hydrogen exchange inhibition
974
Myocardial protection with pinacidil cardioplegia in the blood-perfused heart
975
Myocardial protection with postconditioning is not enhanced by ischemic preconditioning
976
Myocardial protection with potassium-channel openers is as effective as St. Thomasʹ solution in the rabbit heart
977
Myocardial protection with Sevoflurane in Coronary Artery Bypass Grafting Surgery
978
Myocardial Protection with Simultaneous Antegrade/Vein Graft Cardioplegia Compared to Antegrade Cardioplegia Alone in Elective Coronary Artery Bypass Grafting Patients
979
MYOCARDIAL PROTECTION: A CLINICAL COMPARISON OF COLD BLOOD CARDIOPLEGIA AND COLD CRYSTALLOID CARDIOPLEGIA
980
Myocardial protection: Efficacy of RS-C (Aqix®), a novel magnesium-cardioplegia, compared to St Thomasʹ hospital solution
981
Myocardial protection: Modern studies
982
MYOCARDIAL PROTECTION: NEW STRATEGIES FOR PREVENTING LETHAL REFERFUSION INJURY
983
Myocardial protective efficacy of lidocaine (with or without adenosine) as agents to induce polarised cardioplegic arrest during global ischaemia in rat hearts
984
Myocardial recovery after mechanical support for acute myocarditis: is sustained recovery predictable?
985
Myocardial Recovery and the Failing Heart: Myth, Magic, or Molecular Target?
986
Myocardial Redox State Predicts In-Hospital Clinical Outcome After Cardiac Surgery: Effects of Short-Term Pre-Operative Statin Treatment
987
Myocardial regeneration by endogenous adult progenitor cells
988
Myocardial regeneration by human amniotic fluid stem cells: Challenges to be overcome
989
Myocardial Regeneration by Stem Cells: Seeing the Unseeable
990
Myocardial regeneration with bone-marrow-derived stem cells
991
Myocardial regeneration: Roles of stem cells and hydrogels
992
Myocardial Regenerative Therapy: Immunologic Basis for the Potential “Universal Donor Cells”
993
Myocardial remodeling differs between LV and RV myocardium from patients with idiopathic-dilated myocarditis, end-stage heart failure
994
Myocardial Remodeling Is Controlled by Myocyte-Targeted Gene Regulation of Phosphodiesterase Type 5
995
Myocardial remodelling in a mouse model of diabetic cardiomyopathy
996
Myocardial response to ischemic preconditioning: is it a novel predictor of prognosis?
997
Myocardial revascularisation after acute myocardial infarction
998
Myocardial revascularisation by laser
999
Myocardial revascularisation: the search for the Holy Grail
1000
Myocardial revascularization
